FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.22-SNAPSHOT  |  FHIR Version n/a  User: [n/a]

714213006: Product containing bevacizumab in parenteral dose form (medicinal product form)

Status: current, Sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jan 2016. Module: SNOMED CT core

Descriptions:

Id Description Lang Type Status Case? Module
3708804013 Product containing bevacizumab in parenteral dose form (medicinal product form) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core
3708805014 Bevacizumab-containing product in parenteral dose form en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core
5471781000241119 produit contenant du bévacizumab sous forme parentérale fr Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT Switzerland NRC maintained Module

2 descendants. Search Descendants:

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Product containing bevacizumab in parenteral dose form (medicinal product form) Is a Product containing bevacizumab (medicinal product) true Inferred relationship Some
Product containing bevacizumab in parenteral dose form (medicinal product form) Is a Product manufactured as parenteral dose form (product) true Inferred relationship Some
Product containing bevacizumab in parenteral dose form (medicinal product form) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. Bevacizumab (substance) true Inferred relationship Some 1
Product containing bevacizumab in parenteral dose form (medicinal product form) Has manufactured dose form Parenteral dose form (dose form) true Inferred relationship Some
Product containing bevacizumab in parenteral dose form (medicinal product form) Plays role Antineoplastic therapeutic role false Inferred relationship Some
Inbound Relationships Type Active Source Characteristic Refinability Group
Bevacizumab 25mg/mL injection solution 4mL vial Is a False Product containing bevacizumab in parenteral dose form (medicinal product form) Inferred relationship Some
Bevacizumab 25mg/mL injection solution 16mL vial Is a False Product containing bevacizumab in parenteral dose form (medicinal product form) Inferred relationship Some
Product containing precisely bevacizumab 400 milligram/16 milliliter conventional release solution for injection vial Is a False Product containing bevacizumab in parenteral dose form (medicinal product form) Inferred relationship Some
Product containing precisely bevacizumab 100 milligram/4 milliliter conventional release solution for injection vial Is a False Product containing bevacizumab in parenteral dose form (medicinal product form) Inferred relationship Some
Product containing only bevacizumab in parenteral dose form (medicinal product form) Is a True Product containing bevacizumab in parenteral dose form (medicinal product form) Inferred relationship Some

Reference Sets

Description inactivation indicator reference set

GB English

US English

Back to Start